• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

    5.510 -0.300 (-5.16%)
    Streaming Delayed Price Updated: 1:46 PM EDT, Jul 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Wave Life Sciences Ltd. - Ordinary Shares

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    News headline image
    Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    What Analysts Are Saying About WAVE Life Sciences Stock ↗
     
    Via Benzinga
    News headline image
    Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    What's Going On With Wave Life Sciences Stock On Tuesday? ↗
    Wave Life Sciences reports Phase 1b/2a SELECT-HD trial results for WVE-003 in Huntington's disease, demonstrates promise as a disease-modifying therapy. 
    Via Benzinga
    News headline image
    Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗
     
    Via Benzinga
    News headline image
    WAVE Life Sciences's Earnings Outlook ↗
     
    Via Benzinga
    News headline image
    Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q1 2024 ↗
    WVE stock results show that WAVE Life Sciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
    Appointment builds on Wave’s recent progress advancing innovative genetic targets, such as INHBE, and continues to add significant experience to accelerate the rapid identification and translation of... 
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
    Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024 
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Wave Life Sciences to Present at Upcoming Investor Conferences
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
    Via Benzinga
    News headline image
    American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday ↗
    U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday. 
    Via Benzinga
    Topics Stocks
    News headline image
    Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
    Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
    Via Benzinga
    News headline image
    WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 ↗
    WVE stock results show that WAVE Life Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday ↗
    U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    News headline image
    Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For March 6, 2024 ↗
    Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
    Via Benzinga
    News headline image
    Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    $16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗
    Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    News headline image
    Sarepta Therapeutics Inc.: Why it's a rising gene therapy star
    Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases. 
    Via MarketBeat
    News headline image
    Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.